Mitchell Psotka, MD, PHD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $32,945 | 7 | 79.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,181 | 1 | 10.0% |
| Food and Beverage | $2,850 | 61 | 6.8% |
| Travel and Lodging | $1,708 | 9 | 4.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $34,437 | 16 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $4,181 | 1 | $0 (2023) |
| Abbott Laboratories | $1,166 | 20 | $0 (2022) |
| Medtronic Vascular, Inc. | $833.17 | 9 | $0 (2019) |
| United Therapeutics Corporation | $516.69 | 20 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $190.39 | 3 | $0 (2019) |
| ABIOMED | $162.37 | 3 | $0 (2023) |
| Merck Sharp & Dohme LLC | $102.84 | 1 | $0 (2023) |
| Bayer HealthCare Pharmaceuticals Inc. | $38.53 | 2 | $0 (2020) |
| Gilead Sciences, Inc. | $35.83 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.06 | 1 | United Therapeutics Corporation ($20.06) |
| 2023 | $4,348 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($4,181) |
| 2022 | $152.19 | 2 | Abbott Laboratories ($88.95) |
| 2021 | $189.43 | 5 | ABIOMED ($119.74) |
| 2020 | $23,500 | 10 | Amgen Inc. ($23,426) |
| 2019 | $6,452 | 22 | Amgen Inc. ($5,556) |
| 2018 | $6,174 | 25 | Amgen Inc. ($5,423) |
| 2017 | $848.45 | 9 | Medtronic Vascular, Inc. ($725.65) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/01/2024 | United Therapeutics Corporation | ORENITRAM (Drug), REMODULIN | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 09/30/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $4,181.00 | General |
| Category: DIABETES | ||||||
| 04/15/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $102.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/12/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $42.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/29/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: PAH | ||||||
| 12/16/2022 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $88.95 | General |
| Category: Heart Failure | ||||||
| 01/12/2022 | United Therapeutics Corporation | REMODULIN (Drug), ORENITRAM | Food and Beverage | In-kind items and services | $63.24 | General |
| Category: PAH | ||||||
| 11/03/2021 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $104.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/27/2021 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/14/2021 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $17.61 | General |
| 10/05/2021 | Abbott Laboratories | HeartMate Touch (Device) | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: Heart Failure | ||||||
| 09/20/2021 | Abbott Laboratories | HeartMate 3 Left Ventricular Assist Device (Device) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: Heart Failure | ||||||
| 12/09/2020 | United Therapeutics Corporation | ORENITRAM (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: PAH | ||||||
| 12/07/2020 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $5,500.00 | General |
| 11/23/2020 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $2,975.00 | General |
| 11/20/2020 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $3,570.00 | General |
| 08/07/2020 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $5,500.00 | General |
| 04/07/2020 | Abbott Laboratories | HeartMate 3 Left Ventricular Dev (Device) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 03/11/2020 | Bayer HealthCare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Cardio-pulmonary | ||||||
| 02/12/2020 | United Therapeutics Corporation | ORENITRAM (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: PAH | ||||||
| 01/15/2020 | Amgen Inc. | Corlanor (Drug) | Consulting Fee | Cash or cash equivalent | $5,500.00 | General |
| Category: Cardiology | ||||||
| 01/15/2020 | Amgen Inc. | Corlanor (Drug) | Travel and Lodging | Cash or cash equivalent | $381.05 | General |
| Category: Cardiology | ||||||
| 12/11/2019 | United Therapeutics Corporation | ORENITRAM (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: PAH | ||||||
| 11/16/2019 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $56.25 | General |
| 11/13/2019 | United Therapeutics Corporation | ORENITRAM (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: PAH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 160 | 266 | $79,333 | $23,795 |
| 2022 | 8 | 166 | 332 | $139,138 | $31,720 |
| 2021 | 10 | 210 | 436 | $163,219 | $44,746 |
| 2020 | 8 | 205 | 409 | $106,353 | $29,299 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 61 | 83 | $32,246 | $9,831 | 30.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 39 | $10,596 | $4,030 | 38.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 35 | $6,615 | $2,448 | 37.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 15 | $7,938 | $2,298 | 29.0% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2023 | 13 | 49 | $7,840 | $1,740 | 22.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 12 | 12 | $6,653 | $1,715 | 25.8% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 15 | 18 | $6,863 | $1,545 | 22.5% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 12 | 15 | $582.75 | $187.50 | 32.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 54 | 75 | $27,750 | $9,174 | 33.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 32 | 82 | $21,218 | $6,884 | 32.4% |
| 93505 | Biopsy of heart muscle | Facility | 2022 | 14 | 31 | $58,363 | $6,297 | 10.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 18 | $9,072 | $3,058 | 33.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 12 | 12 | $6,336 | $1,935 | 30.5% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2022 | 12 | 59 | $8,990 | $1,920 | 21.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 28 | $5,040 | $1,575 | 31.3% |
| 76932 | Ultrasonic guidance for biopsy of heart muscle | Facility | 2022 | 13 | 27 | $2,369 | $877.62 | 37.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 54 | 80 | $30,137 | $10,042 | 33.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 34 | 103 | $26,052 | $9,455 | 36.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 11 | 45 | $31,395 | $8,961 | 28.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 22 | 63 | $11,004 | $3,918 | 35.6% |
| 93505 | Biopsy of the wall dividing the left and right heart | Facility | 2021 | 19 | 19 | $35,771 | $3,788 | 10.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 19 | $9,415 | $3,293 | 35.0% |
| 93750 | Evaluation of lower heart chamber assist device with physician analysis | Facility | 2021 | 14 | 68 | $10,115 | $2,427 | 24.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 11 | 11 | $5,792 | $1,784 | 30.8% |
| 94621 | Test for exercise-induced heart and lung stress | Facility | 2021 | 12 | 13 | $2,249 | $621.79 | 27.6% |
About Mitchell Psotka, MD, PHD
Mitchell Psotka, MD, PHD is a Advanced Heart Failure and Transplant Cardiology healthcare provider based in Falls Church, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2010. The National Provider Identifier (NPI) number assigned to this provider is 1942525381.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mitchell Psotka, MD, PHD has received a total of $41,684 in payments from pharmaceutical and medical device companies, with $20.06 received in 2024. These payments were reported across 78 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($32,945).
As a Medicare-enrolled provider, Psotka has provided services to 741 Medicare beneficiaries, totaling 1,443 services with total Medicare billing of $129,561. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Advanced Heart Failure and Transplant Cardiology
- Other Specialties Advanced Heart Failure and Transplant Cardiology, Cardiovascular Disease
- Location Falls Church, VA
- Active Since 03/29/2010
- Last Updated 03/11/2022
- Taxonomy Code 207RA0001X
- Entity Type Individual
- NPI Number 1942525381
Products in Payments
- Corlanor (Drug) $11,381
- JARDIANCE (Drug) $4,181
- HeartWare HVAD (Device) $833.17
- HeartMate 3 Left Ventricular Dev (Device) $476.43
- HeartMate (Device) $445.71
- ORENITRAM (Drug) $302.32
- REMODULIN (Drug) $174.92
- Impella (Device) $162.37
- VERQUVO (Drug) $102.84
- BOSENTAN (Drug) $99.74
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $88.95
- CardioMEMS HF System (Device) $52.81
- OPSUMIT MACITENTAN (Drug) $50.07
- Circulatory Support (Device) $41.73
- Adempas (Drug) $38.53
- Repatha (Biological) $31.00
- HeartMate Touch (Device) $27.61
- HeartMate 3 Left Ventricular Assist Device (Device) $24.47
- TYVASO (Drug) $21.84
- VYNDAQEL (Drug) $20.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Advanced Heart Failure and Transplant Cardiology Doctors in Falls Church
Dr. Palak Shah, M.d., M.s, M.D., M.S
Advanced Heart Failure and Transplant Cardiology — Payments: $169,339
Dr. Shashank Desai, Md, MD
Advanced Heart Failure and Transplant Cardiology — Payments: $110,938
Vanessa Blumer
Advanced Heart Failure and Transplant Cardiology — Payments: $3,600